Batna Journal of Medical Sciences
Volume 11, Numéro 1, Pages 24-32
2026-03-02
Authors : Chabane Melissa . Fetati Habiba . Rouebah Halima . Bouattam Souhila . Zitouni Nourine Saida Hanane . Boudia Fatma . Toumi Houari .
Introduction: Idiopathic pulmonary fibrosis is a rare disease. Its management mobilizes a significant number of human and material resources, increasing the economic burden on the healthcare system. The aim of this study was to evaluate the direct medical costs of managing IPF and its complications, mainly decompensation at the hospital and university establishment of November 1st, 1954 of Oran (EHUO) in Algeria. Patients/materials and methods: This was a descriptive, retrospective study carried out over a five-year period, on patients with pulmonary fibrosis hospitalized at the EHUO. The analyzed costs included the direct costs. The time horizon included the entire duration of patient hospitalization. Results: The study involved 17 IPF patients, predominantly male (15 out of 17, or 88.23%), with a sex ratio (M/F) of 8.5 and a mean age of 68.41 ± 8.63 years. The average cost per patient rose from 394,034.11 DZD for the stable form to 1,185,332.74 DZD for the exacerbated form. The decompensation stage was more costly, averaging 5 710 581,14 DZD per patient. More than three-quarters of expenditure was attributable to hospitalization costs. Conclusion: The results of this study suggest that optimal management of this disease will reduce the costs associated with hospitalizations in the event of complications in order to limiting the economic burden of the disease.
health economics ; exacerbation ; pharmaco-economics study ; cost
بوسالم أحلام
.
عابد يوسف
.
ص 117-132.
Yahia Zeghoudi
.
pages 74-88.
Tahri Horiya
.
Hamzaoui Soumia
.
Belhachem Abdelaali Ali
.
Amara Nihed
.
Karzoun Nadra
.
Rouabah Halima
.
Serradj Amina
.
Toumi Houari
.
pages 28-35.
Lesmar Ahlem
.
Mokrane Zine Labidine
.
Alioua Amina
.
Chaouki Feryel
.
pages 20-24.